Position in ACET
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$836,688
+$543,137 QoQ
Shares Held
96,839
+124.7% QoQ
Ownership
1.03%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 56 holders
Holding Since
Sep 2020
22 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in ACET Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,273,664,878 across 342 Biotechnology names. ACET ranks #214 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in ACET
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $836,688 | 96,839 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $293,551 | 43,106 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,219,182 | 144,796 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $692,200 | 854,568 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $312,812 | 512,807 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $373,708 | 494,978 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $676,633 | 703,361 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,012,923 | 703,419 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $763,620 | 631,091 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,225,691 | 521,571 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $681,770 | 360,725 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $308,682 | 225,316 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $375,758 | 154,633 | Shares | Sole | 2023-08-14 | |
| 2022-09-30 | $204,398 | 14,374 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,807,648 | 329,291 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $7,844,176 | 392,798 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $12,306,051 | 703,605 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $606,839 | 77,403 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,383,274 | 134,429 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,339,967 | 102,444 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $382,272 | 27,208 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $121,563 | 10,224 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||